Cargando…

Improving volumetric productivity of a stable human CAP cell line by bioprocess optimization

Detalles Bibliográficos
Autores principales:	Essers, Ruth, Kewes, Helmut, Schiedner, Gudrun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284939/ https://www.ncbi.nlm.nih.gov/pubmed/22373410 http://dx.doi.org/10.1186/1753-6561-5-S8-P66

Ejemplares similares

CAP-T cell expression system: a novel rapid and versatile human cell expression system for fast and high yield transient protein expression
por: Wölfel, Jens, et al.
Publicado: (2011)

Efficient and reproducible generation of high-expressing, stable human cell lines without need for antibiotic selection
por: Schiedner, Gudrun, et al.
Publicado: (2008)

Targeted metabolomics for bioprocessing
por: Sonntag, Denise, et al.
Publicado: (2011)

Toolbox approach for fast generation of stable CHO production cell lines from different hosts
por: Seitz, Susanne, et al.
Publicado: (2011)

k(L)a as a predictor for probe-independent mammalian cell bioprocesses in orbitally shaken bioreactors
por: Tissot, Stéphanie, et al.
Publicado: (2011)

P02-029 - CAPS or SJIA
por: Alekseeva, E, et al.
Publicado: (2013)

PW02-031 - Genetic and clinical manifestations of CAPS
por: Bybee, AK, et al.
Publicado: (2013)

PCM-cap to provide thermal comfort for human head
por: Sezgin, Yigit Can, et al.
Publicado: (2015)

PW02-041 - Canakinumab treatment regimens in CAPS-patients
por: Hofer, F, et al.
Publicado: (2013)

P02-027 - Quality of life in CAPS treated by Canakinumab
por: Marsaud, C, et al.
Publicado: (2013)

P02-033 - CAPS diagnosis and treatment in an Israeli family
por: Shinar, Y, et al.
Publicado: (2013)

PW02-027 - CAPS and cost-effectiveness analysis project
por: Alberighi, O Della Casa, et al.
Publicado: (2013)

PW02-037 - The Eurofever cohort of 136 patients with CAPS
por: Levy, R, et al.
Publicado: (2013)

PW02-033 - Cytokine profile in CSF in CAPS patients
por: Schuh, E, et al.
Publicado: (2013)

Influence of glutamine on transient and stable recombinant protein production in CHO and HEK-293 cells
por: Rajendra, Yashas, et al.
Publicado: (2011)

Does earlier use of productivity enhancers during cell line selection lead to the identification of more productive cell lines?
por: Porter, Alison J, et al.
Publicado: (2011)

Impact on product quality of high productive GS-CHO cell lines
por: Perani, Angelo, et al.
Publicado: (2011)

P02-032 - CAPS: a novel mutation and an unusual phenotype
por: Insalaco, A, et al.
Publicado: (2013)

PW02-025 - Programme necrosis by CAPS-associated NLRP3
por: Satoh, T, et al.
Publicado: (2013)

P02-020 - CAPS in Turkish children: treatment with ANTI IL1
por: Eroglu, FK Kara, et al.
Publicado: (2013)

PW02-034 - NLRP3 mosaicism detection in CAPS using NGS
por: Stoffels, M, et al.
Publicado: (2013)

PW02-026 - Low frequency variants of NLRP3 in CAPS patients
por: Lesche, M, et al.
Publicado: (2013)

PW02-039 - Long-term anakinra treatment in CAPS: a metaanalys
por: Leinonen, M, et al.
Publicado: (2013)

P02-021 - Atypical CAPS consequence of novel NLPR3 mutations
por: Gonzalez-Roca, E, et al.
Publicado: (2013)

Expression of glycoproteins with excellent glycosylation profile and serum half-life in CAP-Go cells
por: Wissing, Silke, et al.
Publicado: (2015)

Production of mannosylglycerate in Saccharomyces cerevisiae by metabolic engineering and bioprocess optimization
por: Faria, Cristiana, et al.
Publicado: (2018)

Consolidated bioprocessing for butanol production of cellulolytic Clostridia: development and optimization
por: Wen, Zhiqiang, et al.
Publicado: (2019)

Avian cell line - Technology for large scale vaccine production
por: Kraus, Barbara, et al.
Publicado: (2011)

Physical methods for synchronization of a human production cell line
por: Platas Barradas, Oscar, et al.
Publicado: (2011)

Recombinant antibody mixtures; optimization of cell line generation and single-batch manufacturing processes
por: Rasmussen, Søren K, et al.
Publicado: (2011)

PW03-020 – A decade of ANTI-IL-1 therpay for CAPS in the UK
por: Lane, T, et al.
Publicado: (2013)

P02-023 - NLRP3 mosaicism as a cause of late-onset CAPS
por: Zhou, Q, et al.
Publicado: (2013)

PW02-028 - Association of novel NLRP3 mutations with CAPS phenotype in Turkish patients
por: Berdeli, A, et al.
Publicado: (2013)

Increasing productivity of hybridoma cell lines by sorting by side scattering light
por: Landgrebe, Daniel, et al.
Publicado: (2011)

P02-026 - Model-based characterization of the PKPD relationship for canakinumab in CAPS: a step towards personalized
por: Gautier, A, et al.
Publicado: (2013)

About making a CHO production cell line “research-friendly” by genetic engineering
por: Voedisch, Bernd, et al.
Publicado: (2011)

Genetic and bioprocess engineering to improve squalene production in Yarrowia lipolytica
por: Liu, Huan, et al.
Publicado: (2020)

Medium and feed optimization for fed-batch production of a monoclonal antibody in CHO cells
por: Kochanowski, Nadine, et al.
Publicado: (2011)

Complex medium supplements optimized for the reduction of animal-derived components in vaccine production media
por: Babcock, James F, et al.
Publicado: (2011)

(13)C-stable isotope analyses technique for ICU patients
por: Hölscher, U, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_tmb5ojr9fv0g5v3mvigihm1il6